TLT Stock UPDATES 20+ Year Trsy Bond Ishares (TLT) 113.09 09/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
20+ Year Trsy Bond Ishares (TLT) 113.09 $TLT

Stocks' Stunning Surge Sets the Table for Possible Fed Action Wednesday
at The Street - Tue Sep 16, 4:44PM CDT
The stock indexes turned around big in midday trading after starting lower.

Short-Term Bond Yields Rising: Where to Go Now for Fixed Income ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Sep 15, 9:00AM CDT
With short term bond yields rising, investors have some intresting choices for how to stay in the fixed income ETF world.

Stock Market Continues Fall; Time to Buy Bonds and Gold
at The Street - Fri Sep 12, 4:41PM CDT
The stock indexes finished off of their lows of the day with a good amount of selling across the board.

SmarTrend Watching for Potential Rebound in Shares of iShares Barclays 20+ Year Treasury Bond Fund After 1.05% Loss
Comtex SmarTrend(R) - Fri Sep 12, 3:41PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $113.22 to a high of $113.92. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $114.57 on volume of 11.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares Barclays 20+ Year Treasury Bond Fund Set to Possibly Rebound After Yesterday's Selloff of 1.05%
Comtex SmarTrend(R) - Fri Sep 12, 3:40PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $113.22 to a high of $113.92. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $114.57 on volume of 11.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

CIR, EDV, VRTS, AHC, VV, TLT Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Sep 12, 5:19AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of CIRCOR INTERNATIONAL, INC. (NYSE:CIR), VANGUARD EXTENDED DUR TREAS (NYSE:EDV), Virtus Investment Partners Inc (NASDAQ:VRTS), A. H. Belo Corp (NYSE:AHC), Versatile Systems Inc (NYSE:VV), iShares Barclays 20+ Year Treasury Bond Fund (NYSE:TLT) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

'Fast Money' Recap: Protecting Yourself Before the Next Fed Meeting
at The Street - Fri Sep 12, 4:00AM CDT
The trading panel discussed whether the central bank will be more hawkish at next week's meeting.

Regional Banks Gaining on Fed's Possible Hawkish Change on Rates
at The Street - Thu Sep 11, 11:28AM CDT
Shares of regional banks have been in demand in anticipation of a change in the Federal Reserve's position at its meeting next week.

Why are Treasury Yields Rising? - Real Time Insight
Todd Bunton - ZACKS - Wed Sep 10, 2:05PM CDT
The yield on the 10-year has risen almost every day since August 28. Why? And will it continue?

Labor Market Woes Lead Dividend Stocks Higher as Interest Rates Lay Low
at The Street - Mon Sep 08, 1:15PM CDT
Latest weak payrolls figure signals U.S. rates may remain low, keeping demand for dividend yielding stocks strong.

'Fast Money' Recap: Stocks Climb, Bonds Fall This Week
at The Street - Sat Sep 06, 4:00AM CDT
The trading panel discussed the overall market and whether to trade Chinese stocks.

'Fast Money' Recap: The European Central Bank and Bonds
at The Street - Fri Sep 05, 4:00AM CDT
The trading panel discussed whether bond yields can go lower and whether you should be long Intel and El Pollo Loco.

Look for Shares of iShares Barclays 20+ Year Treasury Bond Fund to Potentially Rebound after Yesterday's 1.95% Sell Off
Comtex SmarTrend(R) - Tue Sep 02, 3:41PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $116.70 to a high of $117.38. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $117.40 on volume of 10.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares Barclays 20+ Year Treasury Bond Fund Crosses Below its 10-day MA (TLT) - September 02, 2014
Comtex SmarTrend(R) - Tue Sep 02, 9:50AM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) shares have crossed bearishly below their 10-day moving average of $117.47 on a volume of 2.9 million shares. This may provide swing traders with an opportunity for a short position, as such a crossover often suggests lower prices in the near term.In the past 52 weeks, shares of iShares Barclays 20+ Year Treasury Bond Fund have traded between a low of $101.17 and a high of $119.43 and are now at $117.14, which is 16% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 0.6%.

Another Month Over, Another Stock Market Closing High on No Volume
at The Street - Fri Aug 29, 4:40PM CDT
The stock indexes finished the month of August at new all-time highs. August volume was one of the lowest in years.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading